Literature DB >> 28233284

"Brain-muscle loop" in the fragility of older persons: from pathophysiology to new organizing models.

Fulvio Lauretani1,2, Tiziana Meschi3, Andrea Ticinesi3, Marcello Maggio4,5.   

Abstract

BACKGROUND: The imperative action of the geriatric medicine is to prevent disability in older persons. Many epidemiological studies have been conducted in the last decades for improving knowledge of the aging process and their interactions with age-related diseases, especially for the identification of the relationship between sarcopenia and loss of mobility. Factors influencing muscle integrity can be classified into six main physiologic subsystems, but the central nervous system certainly plays a crucial role for maintaining muscle integrity in older persons. Recent data show that the reduced muscle strength and not muscle mass could be considered the core of the fragility in predicting changes of gait velocity and mobility and conferring a higher risk of mortality in older persons. Sarcopenia and cognitive decline could, therefore, produce slow gait velocity in older persons, with devastating effect and consequences. Perhaps the most notorious corollary is falling, which is often caused by an underlying gait problem. Injuries caused by accidental falls range from relatively innocent bruises to major fractures or head trauma. Another important consequence is reduced mobility, which leads to loss of independence. This immobility is often compounded by a fear of falling, which further immobilises patients and affects their quality of life and physical performance. HYPOTHESIS: When we search the association between brain pathology and muscle function in older persons, we amazingly find that established composite measure of physical frailty is associated with brain pathology. Sarcopenia, which produces muscle dysfunction, slow gait velocity and cognitive decline, could share a strong bidirectional relationship, and this suggests the coexistence of both cognitive and motor dysfunctions in older persons to characterize a new syndrome characterized by slow gait and cognitive complaints, the motoric-cognitive risk syndrome (MRC). AIM: In this review, we want to emphasize the relationship between memory complaints with muscle function integrating cognitive and physical evaluation, even with amyloid PET study, to identify older patients at high risk of cognitive and physical decline.

Entities:  

Keywords:  Cognitive impairment; Motoric cognitive risk syndrome; Older persons; Sarcopenia

Mesh:

Year:  2017        PMID: 28233284     DOI: 10.1007/s40520-017-0729-4

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  13 in total

1.  From cognitive to motor impairment and from sarcopenia to cognitive impairment: a bidirectional pathway towards frailty and disability.

Authors:  Giorgio Basile; Alberto Sardella
Journal:  Aging Clin Exp Res       Date:  2020-04-10       Impact factor: 3.636

2.  Frailty, Neurocognitive Impairment, or Both in Predicting Poor Health Outcomes Among Adults Living With Human Immunodeficiency Virus.

Authors:  Kristine M Erlandson; Jeremiah Perez; Mona Abdo; Kevin Robertson; Ronald J Ellis; Susan L Koletar; Robert Kalayjian; Babafemi Taiwo; Frank J Palella; Katherine Tassiopoulos
Journal:  Clin Infect Dis       Date:  2019-01-01       Impact factor: 9.079

3.  Recent advances in cholinergic imaging and cognitive decline-Revisiting the cholinergic hypothesis of dementia.

Authors:  Nicolaas I Bohnen; Michel J Grothe; Nicola J Ray; Martijn L T M Müller; Stefan J Teipel
Journal:  Curr Geriatr Rep       Date:  2018-01-13

Review 4.  Aging Gut Microbiota at the Cross-Road between Nutrition, Physical Frailty, and Sarcopenia: Is There a Gut-Muscle Axis?

Authors:  Andrea Ticinesi; Fulvio Lauretani; Christian Milani; Antonio Nouvenne; Claudio Tana; Daniele Del Rio; Marcello Maggio; Marco Ventura; Tiziana Meschi
Journal:  Nutrients       Date:  2017-11-30       Impact factor: 5.717

Review 5.  Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention.

Authors:  Francesco Panza; Madia Lozupone; Vincenzo Solfrizzi; Rodolfo Sardone; Vittorio Dibello; Luca Di Lena; Francesca D'Urso; Roberta Stallone; Massimo Petruzzi; Gianluigi Giannelli; Nicola Quaranta; Antonello Bellomo; Antonio Greco; Antonio Daniele; Davide Seripa; Giancarlo Logroscino
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 6.  Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson's Disease and Parkinsonism.

Authors:  Claudio Tana; Fulvio Lauretani; Andrea Ticinesi; Beatrice Prati; Antonio Nouvenne; Tiziana Meschi
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

7.  Muscle weakness, cognitive impairment and their interaction on altered balance in elderly outpatients: results from the TRIP observational study.

Authors:  Fulvio Lauretani; Marcello Maggio; Andrea Ticinesi; Claudio Tana; Beatrice Prati; Luciano Gionti; Antonio Nouvenne; Tiziana Meschi
Journal:  Clin Interv Aging       Date:  2018-08-21       Impact factor: 4.458

Review 8.  Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review.

Authors:  Andrea Ticinesi; Claudio Tana; Antonio Nouvenne; Beatrice Prati; Fulvio Lauretani; Tiziana Meschi
Journal:  Clin Interv Aging       Date:  2018-08-29       Impact factor: 4.458

Review 9.  Proactive interception and care of Frailty and Multimorbidity in older persons: the experience of the European Innovation Partnership on Active and Healthy Ageing and the response of Parma Local Health Trust and Lab through European Projects.

Authors:  Yari Longobucco; Chiara Benedetti; Sara Tagliaferri; Vincenza Valentina Angileri; Elisa Adorni; Michele Pessina; Luna Zerbinati; Lorenzo Cicala; Giovanna Pelà; Vittoria Giacomini; Mirca Barbolini; Fulvio Lauretani; Marcello Giuseppe Maggio
Journal:  Acta Biomed       Date:  2019-05-23

10.  Prevalence, incidence, and clinical impact of cognitive-motoric risk syndrome in Europe, USA, and Japan: facts and numbers update 2019.

Authors:  Marcello Maggio; Fulvio Lauretani
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-08-13       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.